|  | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|
Factor | No. | Median | 95% CI | P | HR | 95% CI | P |
Age | Â | Â | Â | 0.55 | Â | Â | Â |
  ≤ 40 | 29 | 6.4 | 1.7–11.1 |  |  |  |  |
  > 40 | 98 | 7.3 | 6.1–8.5 |  |  |  |  |
DFI | Â | Â | Â | 0.33 | Â | Â | Â |
  ≤ 1 y | 31 | 7.6 | 4.7–10.5 |  |  |  |  |
  > 1 y | 76 | 7.6 | 4.5–11.7 |  |  |  |  |
 IV | 20 | 5.4 |  |  |  |  |  |
KPS | Â | Â | Â | 0.000 | Â | Â | 0.07 |
 70–100 | 109 | 7.6 | 4.7–10.4 |  | 1.81 |  |  |
 40–60 | 18 | 1.7 | 0.2–3.4 |  |  |  |  |
Recurrent BM | Â | Â | Â | 0.008 | Â | Â | 0.01 |
 First | 32 | 17.3 | 9.2–25.3 |  | 2.21 | 1.18–4.17 |  |
 Subsequent | 95 | 6.3 | 4.5–8.0 |  |  |  |  |
Number of intracranial metastases | Â | Â | Â | 0.002 | Â | Â | 0.001 |
  > 3 | 58 | 5.4 | 2.1–8.7 |  | 2.37 | 1.47–3.80 |  |
  ≤ 3 | 69 | 10.2 | 6.3–14.1 |  |  |  |  |
Symptomatic brain metastasis | Â | Â | Â | 0.02 | Â | Â | 0.01 |
 Presence | 76 | 5.5 | 2.8–8.2 |  | 1.92 | 1.13–3.27 |  |
 Absence | 51 | 8.7 | 3.0–16.7 |  |  |  |  |
Meninges involvement | Â | Â | Â | 0.01 | Â | Â | 0.48 |
 Yes | 14 | 3.2 | 0.9–5.4 |  | 1.32 | 0.61–2.83 |  |
 No | 113 | 7.6 | 4.8–10.3 |  |  |  |  |
Brain-directed treatment | Â | Â | Â | 0.001 | Â | Â | 0.002 |
 Not performed | 29 | 3.7 | 0.2–7.7 |  | 2.30 | 1.32–3.92 |  |
 Performed | 98 | 9.5 | 6.3–12.7 |  |  |  |  |
Extracranial metastasisa | Â | Â | Â | 0.002 | Â | Â | 0.02 |
 Under-control | 37 | 9.8 | 5.8–13.8 |  | 1.78 | 1.13–2.92 |  |
 Out-of-control | 65 | 3.6 | 2.2–4.9 |  |  |  |  |